Related references
Note: Only part of the references are listed.Parvovirus-Based Combinatorial Immunotherapy: A Reinforced Therapeutic Strategy against Poor-Prognosis Solid Cancers
Assia Angelova et al.
CANCERS (2021)
Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Jacek Hajda et al.
CLINICAL CANCER RESEARCH (2021)
Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry
Amit Kulkarni et al.
NATURE COMMUNICATIONS (2021)
The role of galectins in virus infection - A systemic literature review
Wen-Hung Wang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
A Roadmap for the Success of Oncolytic Parvovirus-Based Anticancer Therapies
Anna Hartley et al.
ANNUAL REVIEW OF VIROLOGY, VOL 7, 2020 (2020)
Oncolytic H-1 Parvovirus Enters Cancer Cells through Clathrin-Mediated Endocytosis
Tiago Ferreira et al.
VIRUSES-BASEL (2020)
Galectins in Intra- and Extracellular Vesicles
Sebastian Baenfer et al.
BIOMOLECULES (2020)
Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastoma
Jubayer A. Hossain et al.
NEURO-ONCOLOGY (2019)
H-1 Parvovirus as a Cancer-Killing Agent: Past, Present, and Future
Clemens Bretscher et al.
VIRUSES-BASEL (2019)
Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study
Antonio Marchini et al.
FRONTIERS IN IMMUNOLOGY (2019)
Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy
Shang-Yu Chou et al.
BMC CANCER (2018)
Role of Galectins in Tumors and in Clinical Immunotherapy
Feng-Cheng Chou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Prognostic significance of galectin-1 expression in patients with cancer: a meta-analysis
Rongzu Wu et al.
CANCER CELL INTERNATIONAL (2018)
Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker
Neus Martinez-Bosch et al.
Oncotarget (2018)
Galectins-1,-3, and-7 Are Prognostic Markers for Survival of Ovarian Cancer Patients
Heiko Schulz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial
Karsten Geletneky et al.
MOLECULAR THERAPY (2017)
Galectin-1 inhibitors and their potential therapeutic applications: a patent review
Helen Blanchard et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Standardized large-scale H-1PV production process with efficient quality and quantity monitoring
Barbara Leuchs et al.
JOURNAL OF VIROLOGICAL METHODS (2016)
Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade
Antonio Marchini et al.
VIRUSES-BASEL (2016)
The Role of Galectin-1 in Cancer Progression, and Synthetic Multivalent Systems for the Study of Galectin-1
Jonathan M. Cousin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Galectin-3 plays a role in minute virus of mice infection
Pierre O. Garcin et al.
VIROLOGY (2015)
Timing of Galectin-1 Exposure Differentially Modulates Nipah Virus Entry and Syncytium Formation in Endothelial Cells
Omai B. Garner et al.
JOURNAL OF VIROLOGY (2015)
Enterovirus 71 Virion-Associated Galectin-1 Facilitates Viral Replication and Stability
Pei-Huan Lee et al.
PLOS ONE (2015)
Unraveling galectin-1 as a novel therapeutic target for cancer
Lucile Astorgues-Xerri et al.
CANCER TREATMENT REVIEWS (2014)
Altered galectin-1 serum levels in patients diagnosed with high-grade glioma
Tina Verschuere et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Proteomic analysis identifies a novel function for galectin-3 in the cell entry of parvovirus
Pierre Garcin et al.
JOURNAL OF PROTEOMICS (2013)
Structural Characterization of H-1 Parvovirus: Comparison of Infectious Virions to Empty Capsids
Sujata Halder et al.
JOURNAL OF VIROLOGY (2013)
Clinicopathological and prognostic significance of galectin-1 and vascular endothelial growth factor expression in gastric cancer
Jie Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Diversity in recognition of glycans by F-type lectins and galectins: molecular, structural, and biophysical aspects
Gerardo R. Vasta et al.
GLYCOBIOLOGY OF THE IMMUNE RESPONSE (2012)
Galectin-3 endocytosis by carbohydrate independent and dependent pathways in different macrophage like cell types
Adriana Lepur et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Molecular Pathways: Rodent Parvoviruses-Mechanisms of Oncolysis and Prospects for Clinical Cancer Treatment
Juerg P. F. Nueesch et al.
CLINICAL CANCER RESEARCH (2012)
Retargeting of Rat Parvovirus H-1PV to Cancer Cells through Genetic Engineering of the Viral Capsid
Xavier Allaume et al.
JOURNAL OF VIROLOGY (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Efficient Recombinant Parvovirus Production with the Help of Adenovirus-derived Systems
Nazim El-Andaloussi et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2012)
Novel adenovirus-based helper system to support production of recombinant parvovirus
N. El-Andaloussi et al.
CANCER GENE THERAPY (2011)
Galectin-1 Binds to Influenza Virus and Ameliorates Influenza Virus Pathogenesis
Mei-Lin Yang et al.
JOURNAL OF VIROLOGY (2011)
Lactose Binding to Galectin-1 Modulates Structural Dynamics, Increases Conformational Entropy, and Occurs with Apparent Negative Cooperativity
Irina V. Nesmelova et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Through Its Nonstructural Protein NS1, Parvovirus H-1 Induces Apoptosis via Accumulation of Reactive Oxygen Species
Georgi Hristov et al.
JOURNAL OF VIROLOGY (2010)
Endothelial Galectin-1 Binds to Specific Glycans on Nipah Virus Fusion Protein and Inhibits Maturation, Mobility, and Function to Block Syncytia Formation
Omai B. Garner et al.
PLOS PATHOGENS (2010)
Galectin-glycan lattices regulate cell-surface glycoprotein organization and signalling
Omai B. Garner et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Co-localization of galectin-1 with GM1 ganglioside in the course of its clathrin- and raft-dependent endocytosis
R. Fajka-Boja et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines
Tae-Young Jung et al.
JOURNAL OF NEUROSURGERY (2008)
Galectin-1 promotes HIV-1 infectivity in macrophages through stabilization of viral adsorption
Simon Mercier et al.
VIROLOGY (2008)
Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival
M. T. Elola et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
The NCI60 human tumour cell line anticancer drug screen
Robert H. Shoemaker
NATURE REVIEWS CANCER (2006)
Novel innate immune functions for galectin-1: Galectin-1 inhibits cell fusion by nipah virus envelope glycoproteins and augments dendritic cell secretion of proinflammatory cytokines
EL Levroney et al.
JOURNAL OF IMMUNOLOGY (2005)
Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells
M Ouellet et al.
JOURNAL OF IMMUNOLOGY (2005)
Parvovirus H-1 infection of human glioma cells leads to complete viral replication and efficient cell killing
MHY Calle et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Binding and cross-linking properties of galectins
CF Brewer
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2002)
Galectin 1 is involved in vascular smooth muscle cell proliferation
EP Moiseeva et al.
CARDIOVASCULAR RESEARCH (2000)
Share Paper
